Human S-adenosylhomocysteine hydrolase: Common gene sequence variation and functional genomic characterization

Journal of Neurochemistry

Volumn 110, Issue 6, 2009, Pages 1806-1817

  Feng, Qiping ^a   Keshtgarpour, Mani ^a   Pelleymounter, Linda L ^a   Moon, Irene ^a   Kalari, Krishna R ^b   Eckloff, Bruce W ^a   Wieben, Eric D ^a   Weinshilboum, Richard M ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

AHCY; Functional genomics; Gene resequencing; Gene sequence variation; S adenosylhomocysteine hydrolase; Single nucleotide polymorphisms

Indexed keywords

ADENOSYLHOMOCYSTEINASE; ALLOENZYME; NEUROTRANSMITTER;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DNA METHYLATION; DNA SEQUENCE; ENZYME ACTIVITY; FUNCTIONAL GENOMICS; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOSYLHOMOCYSTEINASE; AMINO ACID SEQUENCE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; GENETIC VARIATION; GENOMICS; HUMANS; LINKAGE DISEQUILIBRIUM; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POPULATION GROUPS;

MAMMALIA;

EID: 69949137188     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06276.x     Document Type: Article

References (42)

1. Ando T., Kojima K., Chahota P., Kozaki A., Milind N. D. Kitade Y. (2008) Synthesis of 4′-modified noraristeromycins to clarify the effect of the 4′-hydroxyl groups for inhibitory activity against S-adenosyl-L- homocysteine hydrolase. Bioorg. Med. Chem. Lett. 18, 2615 2618.
2. Axelrod J. (1962a) The enzymatic N-methylation of serotonin and other amines. J. Pharmacol. Exp. Ther. 138, 28 33.
3. Axelrod J. (1962b) Purification and properties of phenylethanolamine-N- methyl transferase. J. Biol. Chem. 237, 1657 1660.
4. Axelrod J. Cohn C. K. (1971) Methyltransferase enzymes in red blood cells. J. Pharmacol. Exp. Ther. 176, 650 654.
5. Axelrod J. Tomchick R. (1958) Enzymatic O-methylation of epinephrine and other catechols. J. Biol. Chem. 233, 702 705.
6. Axelrod J., Wurtman R. J. Snyder S. H. (1965) Control of hydroxyindole O-methyltransferase activity in the rat pineal gland by environmental lighting. J. Biol. Chem. 240, 949 954.
7. Baric I., Fumic K., Glenn B. et al. (2004) S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc. Natl Acad. Sci. USA 101, 4234 4239.
8. Baric I., Cuk M., Fumic K. et al. (2005) S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy. J. Inherit. Metab. Dis. 28, 885 902.
9. Borchardt R. T. (1980) S-Adenosyl-L-methionine-dependent macromolecule methyltransferases: potential targets for the design of chemotherapeutic agents. J. Med. Chem. 23, 347 357.
10. Brodde O. E. Leineweber K. (2005) Beta2-adrenoceptor gene polymorphisms. Pharmacogenet. Genomics 15, 267 275.
11. Buist N. R., Glenn B., Vugrek O. et al. (2006) S-adenosylhomocysteine hydrolase deficiency in a 26-year-old man. J. Inherit. Metab. Dis. 29, 538 545.
12. Cantoni G. L. (1975) Biological methylation: selected aspects. Annu. Rev. Biochem. 44, 435 451.
13. Castro R., Rivera I., Martins C. et al. (2005) Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC. J. Mol. Med. 83, 831 836.
14. Chiang P. K. (1998) Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. Pharmacol. Ther. 77, 115 134.
15. Chiang P. K., Gordon R. K., Tal J., Zeng G. C., Doctor B. P., Pardhasaradhi K. McCann P. P. (1996) S-Adenosylmethionine and methylation. FASEB J. 10, 471 480.
16. Donohue S. J., Roseboom P. H., Illnerova H., Weller J. L. Klein D. C. (1993) Human hydroxyindole-O-methyltransferase: presence of LINE-1 fragment in a cDNA clone and pineal mRNA. DNA Cell Biol. 12, 715 727.
17. Elrod P., Zhang J., Yang X., Yin D., Hu Y., Borchardt R. T. Schowen R. L. (2002) Contributions of active site residues to the partial and overall catalytic activities of human S-adenosylhomocysteine hydrolase. Biochemistry 41, 8134 8142.
18. Finkelstein J. D. (2007) Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin. Chem. Lab. Med. 45, 1694 1699.
19. Fumic K., Beluzic R., Cuk M., Pavkov T., Kloor D., Baric I., Mijic I. Vugrek O. (2007) Functional analysis of human S-adenosylhomocysteine hydrolase isoforms SAHH-2 and SAHH-3. Eur. J. Hum. Genet. 15, 347 351.
20. Gellekink H., den Heijer M., Kluijtmans L. A. Blom H. J. (2004) Effect of genetic variation in the human S-adenosylhomocysteine hydrolase gene on total homocysteine concentrations and risk of recurrent venous thrombosis. Eur. J. Hum. Genet. 12, 942 948.
21. Goggins M., Scott J. M. Weir D. G. (1999) Methylation of cortical brain proteins from patients with HIV infection. Acta Neurol. Scand. 100, 326 331.
22. Hall C. V., Jacob P. E., Ringold G. M. Lee F. (1983) Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J. Mol. Appl. Genet. 2, 101 109.
23. Honchel R., Aksoy I., Szumlanski C., Wood T. C., Otterness D. M., Wieben E. D. Weinshilboum R. M. (1993) Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA. Mol. Pharmacol. 43, 878 887.
24. Ji Y., Salavaggione O. E., Wang L., Adjei A. A., Eckloff B., Wieben E. D. Weinshilboum R. M. (2005) Human phenylethanolamine N-methyltransferase pharmacogenomics: gene re-sequencing and functional genomics. J. Neurochem. 95, 1766 1776.
25. Lachman H. M., Papolos D. F., Saito T., Yu Y. M., Szumlanski C. L. Weinshilboum R. M. (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6, 243 250.
26. Lamba J. K., Lin Y. S., Schuetz E. G. Thummel K. E. (2002) Genetic contribution to variable human CYP3A-mediated metabolism. Adv. Drug Deliv. Rev. 54, 1271 1294.
27. Li F., Feng Q., Lee C. et al. (2008) Human betaine-homocysteine methyltransferase (BHMT) and BHMT2: common gene sequence variation and functional characterization. Mol. Genet. Metab. 94, 326 335.
28. Liu S., Wolfe M. S. Borchardt R. T. (1992) Rational approaches to the design of antiviral agents based on S-adenosyl-L-homocysteine hydrolase as a molecular target. Antiviral Res. 19, 247 265.
29. Loehrer F. M., Angst C. P., Brunner F. P., Haefeli W. E. Fowler B. (1998) Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions? Nephrol. Dial. Transplant. 13, 656 661.
30. McKeever M., Molloy A., Weir D. G., Young P. B., Kennedy D. G., Kennedy S. Scott J. M. (1995a) An abnormal methylation ratio induces hypomethylation in vitro in the brain of pig and man, but not in rat. Clin. Sci. (Lond) 88, 73 79.
31. McKeever M., Molloy A., Young P., Kennedy S., Kennedy D. G., Scott J. M. Weir D. G. (1995b) Demonstration of hypomethylation of proteins in the brain of pigs (but not in rats) associated with chronic vitamin B12 inactivation. Clin. Sci. (Lond) 88, 471 477.
32. Miller M. W., Duhl D. M., Winkes B. M., Arredondo-Vega F., Saxon P. J., Wolff G. L., Epstein C. J., Hershfield M. S. Barsh G. S. (1994) The mouse lethal nonagouti (a(x)) mutation deletes the S-adenosylhomocysteine hydrolase (Ahcy) gene. EMBO J. 13, 1806 1816.
33. Palmer J. L. Abeles R. H. (1976) Mechanism for enzymatic thioether formation. Mechanism of action of S-adenosylhomocysteinase. J. Biol. Chem. 251, 5817 5819.
34. Purcell S., Neale B., Todd-Brown K. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559 575.
35. Rosenthal N. (1987) Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol. 152, 704 720.
36. Schaid D. J., Rowland C. M., Tines D. E., Jacobson R. M. Poland G. A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70, 425 434.
37. Shield A. J., Thomae B. A., Eckloff B. W., Wieben E. D. Weinshilboum R. M. (2004) Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol. Psychiatry 9, 151 160.
38. Szumlanski C., Otterness D., Her C. et al. (1996) Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol. 15, 17 30. (Pubitemid 26029354)
39. Thompson M. A., Moon E., Kim U. J., Xu J., Siciliano M. J. Weinshilboum R. M. (1999) Human indolethylamine N-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization. Genomics 61, 285 297.
40. Tishkoff S. A. Williams S. M. (2002) Genetic analysis of African populations: human evolution and complex disease. Nat. Rev. Genet. 3, 611 621.
41. Weinshilboum R. M. (2006) Pharmacogenomics: catechol O-methyltransferase to thiopurine S-methyltransferase. Cell. Mol. Neurobiol. 26, 539 561.
42. Weinshilboum R. M., Otterness D. M. Szumlanski C. L. (1999) Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu. Rev. Pharmacol. Toxicol. 39, 19 52.